Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02937051 · ClinicalTrials.gov registry record · NA

Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
25
Enrollment target

NCT02937051: Completed NA study, sponsored by Virginia Commonwealth University.

NCT02937051 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02937051, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
25 participants
Enrollment target

Study Summary

This study involves 25 current young adult combustible tobacco cigarette (CTC) smokers who will complete 5 Latin square ordered, within-subject, laboratory conditions that differ by the tobacco product smoked: 1. own-brand CTC (positive control), 2. original-flavored Black \& Mild (B\&M) cigar, 3. apple-flavored B\&M cigar, 4. cream-flavored B\&M cigar, and 5. wine-flavored B\&M cigar.

Primary Outcome

Each participant will attend 5 study sessions, each study session will include two bouts of product administration. Product administration will consist of 10 puffs with a 30-second interpuff interval (IPI; puff number and IPI will be directed and monitored by staff).

Interventions

  • OTHER Tobacco product administration and assessment

Trial Details

FieldValue
Enrollment Target 25 participants
Start Date 2016-10
Est. Completion 2019-04-12
Phase NA
Virginia Commonwealth University

558 total trials

What the finished NCT02937051 record still lists

NCT02937051 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which Tobacco product administration and assessment is the first listed.

NCT02937051 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02937051 about?

NCT02937051 is a clinical study titled "Effects of Cigar Flavors on Measures of Abuse Liability Among Young Adults". This study involves 25 current young adult combustible tobacco cigarette (CTC) smokers who will complete 5 Latin square ordered, within-subject, laboratory conditions that differ by the tobacco product smoked: 1. own-brand CTC (positive control), 2. original-flavored Black \& Mild (B\&M) cigar, 3. ...

What is the current status of trial NCT02937051?

This trial is currently completed. It is a NA study. The enrollment target is 25 participants. The study started on 2016-10. Estimated completion is 2019-04-12.

What interventions are being tested in trial NCT02937051?

The interventions under investigation include: Tobacco product administration and assessment (OTHER).

Who is sponsoring clinical trial NCT02937051?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02937051's enrollment target sits among peer trials

25 1712th of 2000 higher than 265 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01166854 · 25 participants

    Characterization of Familial Myopathy and Paget Disease of Bone

  • NCT01913106 · 25 participants · Phase 1

    HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer

  • NCT02138669 · 25 participants · NA

    Intacs Prescription Inserts for Keratoconus Patients

  • NCT02174549 · 25 participants · Phase 1

    Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02937051, the US trial registry maintained by the National Library of Medicine. NCT02937051 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.